SSSI issued for soon-to-be discontinued insulin product

Pharmacists get the green light to substitute Novo Nordisk’s Ryzodeg (insulin degludec and insulin aspart) 70/30 FlexTouch for the Penfill alternative  The Therapeutic Goods Administration (TGA) has issued a Serious Scarcity Substitution Instrument (SSSI) to help manage the unavailability of Ryzodeg 70/30 FlexTouch insulin prefilled pens.  The product, which manufacturer, Novo Nordisk announced will be